Our company

Surge2Surgery’s objective is to enhance patients’ experience

during the perioperative period

OUR VISION

We believe that fingerprinting the immune system can be a game-changer when it comes to improving the surgical journey for millions of patients. Combining innovative technologies with artificial intelligence, our multidisciplinary team of clinicians, engineers and scientists is focused on holistically improving the standard-of-care.

 

Predicting the risk for complications before surgery is critical to allow personalization of pre-operative clinical interventions, surgical decision-making and improvement of surgical outcomes.

S2Sgroup_edited.jpg

IMPACT

PATIENT

Surge2Surgery promotes clear and fair communication between surgeons and patients allowing them to understand clearly their risks, get accurate information and finally make the right decision

HEALTHCARE SYSTEM

Stratification of at-risk patients before surgery drives clinical decisions to reduce the number of complications, improve patients satisfaction, and ultimately reduce the major burden of complications on the health care system

SCIENCE

Our multidisciplinary team will leverage its multi-omic database to develop the technology and decipher the immune mechanisms that drive recovery or clinical outcomes after systemic aggression

SURGE2SURGERY TEAM

Julien Hedou, MS

MS, CEO

I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me.

FF7FD9E1-2AD3-4F90-BADC-0FB198380CDC.jpe

Julien Hedou, MS

Chief Executive Officer

Data Scientist in Immunology,

Stanford Graduate,

X - 2017

E55D3A7D-3CF2-4542-BEFB-1DD03C6998BA.jpe

Brice Gaudilliere, MD, PhD

Scientific co-founder

Associate Professor of Anesthesiology, Perioperative and Pain Medicine,

Stanford University School of Medicine,
X-1997

5B9DE360-0F8A-4664-A59B-BF713AFBDAB8.jpe

Dyani Jones, DMD, MPH

Chief R&D Officer 

Chief, Section of Oral Medicine and Surgery, Clinical Assistant Professor, Stanford School of Medicine

61C6E48C-4696-436A-8329-28711E8EB44D.jpe

Franck Verdonk, MD, PhD

Chief Medical Officer

Associate Professor of Anesthesiology, Perioperative Medicine and Intensive Care, Sorbonne University, Paris

3FD62A0B-4E5B-47D0-AB62-A972ED0881E7.jpe

Cindy Kin, MD, MS, FACS

Scientific Advisor

Assistant Professor of Surgery,

Stanford University School of Medicine

AC9471C0-4588-4512-B52E-02C4C0B952B8.jpe

Benjamin Choisy, MD

Chief Product Officer

Internal Medicine, Holistic Medicine,

France

1F1CE038-DA7E-40C3-97DB-B0D10C38286D.jpe

Serena Bruckman, PT, NCS

VP Customer Success

Board Certified Neurological Specialist in Physical Therapy, Women's and Men's Health Physical Therapist 

Amy Tsai, BA

MD Candidate, UC Davis
BA in Neurobiology, UC Berkeley

BUSINESS ADVISORY BOARD

Linkedin.png

DANIEL BEHR

Entrepreneurial Leader
Tech commercialization, growth strategies & business development 

Linkedin.png

BARRETT LARSON

Physician Entrepreneur
Founder and Director of the Stanford Anesthesia Innovation Lab

Linkedin.png

VALENTIN PICOT

Legal Counsel

IP protection
Arcelor Mittal, France

Linkedin.png

PIERRE ROCHETEAU

Founder and CEO

Olgram, Biotechnology Company

France